scispace - formally typeset
S

Stuart M. Furler

Researcher at Garvan Institute of Medical Research

Publications -  56
Citations -  3846

Stuart M. Furler is an academic researcher from Garvan Institute of Medical Research. The author has contributed to research in topics: Insulin resistance & Insulin. The author has an hindex of 32, co-authored 56 publications receiving 3736 citations. Previous affiliations of Stuart M. Furler include St. Vincent's Health System.

Papers
More filters
Journal ArticleDOI

Long-chain acyl-CoA esters as indicators of lipid metabolism and insulin sensitivity in rat and human muscle

TL;DR: It is concluded that the LCACoA content of muscle provides a direct index of intracellular lipid metabolism and its links to insulin action, which, unlike triglyceride content, is not subject to contamination by closely associated adipose tissue.
Journal ArticleDOI

The role of intramuscular lipid in insulin resistance

TL;DR: It is postulate that muscle cytosolic accumulation of the metabolically active long-chain fatty acyl CoAs (LCACoA) is involved, leading to insulin resistance and impaired insulin signalling or impaired enzyme activity, and the interactions described here are fundamental to optimizing therapy of insulin resistance based on alterations in muscle lipid metabolism.
Journal ArticleDOI

Exercise increases adiponectin levels and insulin sensitivity in humans.

TL;DR: It is demonstrated that the short-term exercise training increased circulating adiponectin levels with accompanied improved insulin sensitivity, and was an extension to a previously reported exercise intervention in sedentary males.
Journal ArticleDOI

Increased Efficiency of Fatty Acid Uptake Contributes to Lipid Accumulation in Skeletal Muscle of High Fat-Fed Insulin-Resistant Rats

TL;DR: Insulin resistance induced by feeding rats a high-fat diet is associated with tissue-specific adaptations that enhance utilization of increased dietary lipid but could also contribute to the accumulation of intramuscular lipid with a detrimental effect on insulin action.